In this week's video, Dr. Brian Durie answers a patient's concern about the potential of adverse side effects or toxicity issues from long-term Revlimid use.

Discuss with your doctor the pros and cons of Revlimid maintenance.

Have a question? Submit it to

IMF Chairman and Co-Founder Brian G.M. Durie, MD welcomes your questions about the latest myeloma treatments, research, controversies and quality of life issues. If you have a question you think might be of interest to the myeloma community, please send to!

For questions of a specific personal nature, please call the IMF InfoLine coordinators at 800.452.2873 or email them at

Previous Post
What exactly is high-risk myeloma and how should it be treated?
Next Post
Bone and Renal Health

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.